Today, Ryan Modesto and Greg Newman commented about whether PHO.TO, IBM, BEP.UN.TO, ARE.TO, IFC.TO, BPY.UN.TO, QSR.TO, BIP.UN.TO, AQN.TO, UBER, ENB.TO, AMZN, CHE.UN.TO, XGD.TO, CM.TO, MFC.TO, CGX.TO, WMT, SIA.TO, CSH.UN.TO, BYD.TO, LNF.TO, LSPD.TO, SOX.TO, PAT.V, DSG.TO, GUD.TO, WTE.TO, WSP.TO, STN.TO, ATD.B.TO, GC.TO, TCL.A.TO, PYR.TO, TFII.TO, ADN.TO, COV.V, CSW.A.TO, PBH.TO, TSGI.TO are stocks to buy or sell.
They are focused on retail and restaurant sector. A great example of a Canadian growth company that does not get enough interest. One of the highest growth companies on the TSX. A good software company with high recurring revenues. Cheaper than Shopify. Yield 0% (Analysts’ price target is $29.20)
Chartwell vs. Sienna for growth He likes and owns both. CSH's latest report says their operating income grew an impressive 4.7%, but Sienna's was 5.4%. CSH's and Sienna's growth are 5-5.5%. CSH has a low 64% payout ratio, but Sienna is a little cheaper at 12.7x vs. CSH's 15.6x. They're similar in many ways, but Sienna has more room for multiple expansion/upside. But CSH is slightly safer because it has a bigger cap. Both are in a good space with demographics as a tailwind.
Chartwell vs. Sienna for growth He likes and owns both. CSH's latest report says their operating income grew an impressive 4.7%, but Sienna's was 5.4%. CSH's and Sienna's growth are 5-5.5%. CSH has a low 64% payout ratio, but Sienna is a little cheaper at 12.7x vs. CSH's 15.6x. They're similar in many ways, but Sienna has more room for multiple expansion/upside. But CSH is slightly safer because it has a bigger cap. Both are in a good space with demographics as a tailwind.
Very good company and well-run. There's enough room for this and Amazon to both do well. Buy this on a pullback. He's long held this.
Dividend safe at 7.5%? CGX has an unsustainable 167% payout ratio to free cash flow. Their PE is pricey. They've spent a lot of non-movie ventures, but movies still account for 45% of business plus 25% in concessions. They need people coming into movie to attain growth. You can buy a little of this like around $23. It's an okay name, but has risk.
Pros and cons. Yes, they won the trial, but there remains a litigation overhang (they should win their appeal). They just had a good quarter, but it was driven by Asia--is this sustainable? He expects 9% EPS growth and 10% annual dividend growth. Trades around 7x. It's outstanding value, but all insurance companies are hurt by falling interest rates. MFC has done a great job diversifying away from that, though.